Frank Carillo is CEO of ECG, Inc. ECG’s Healthcare communications practice is dedicated to making sure that bad communication does not ruin good science. ECG prepares and coaches pharmaceutical executives, health care providers, and experts from academia for important medical and regulatory interactions. Frank’s primary work is with clients who must present new drug applications to FDA Advisory Committee meetings and other global health authorities for approval. In doing so, ECG has achieved an impressive record of success supporting over 230 filings. Frank and ECG are committed to building the explanations and advocacy necessary for helping regulators and academicians see new data in an appropriate benefit-risk context.